AAP Updates Guidance on Evaluation, Treatment of Patent Ductus Arteriosus in Preemies
By Elana Gotkine HealthDay Reporter
THURSDAY, May 15, 2025 -- In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance on the evaluation and treatment of patent ductus arteriosus (PDA) in preterm infants.
Namasivayam Ambalavanan, M.D., from the University of Alabama at Birmingham, and colleagues reviewed the available evidence to develop guidelines for evaluation and treatment of preterm infants with prolonged ductal patency.
The authors note that delayed closure of PDA is common in preterm infants, especially at more extreme immaturity. Echocardiography is essential for confirming PDA presence and assessing its hemodynamic significance. For a hemodynamically significant PDA (hsPDA), medical closure using ibuprofen or acetaminophen is an option. Recent data indicate the lack of benefits of prophylactic or early (age <2 weeks) medical PDA closure versus expectant management and, consequently, they are not recommended. Since the relative benefits and risks of expectant management with close monitoring, attempted pharmacologic closure, or procedural (transcatheter/surgical) closure have not been adequately defined, data are insufficient to support firm recommendations on management of infants with an hsPDA beyond 2 weeks of age. Medical closure of an hsPDA beyond 2 weeks of age is attempted by many clinicians. Infants may be considered for transcatheter closure or surgical ligation if the hsPDA persists despite medical therapy (or if medical therapy is contraindicated). Surgical closure of the PDA has become less frequent in recent years, and in many centers, transcatheter closure is more common.
"There is a lack of evidence to guide management, necessitating equipoise regarding treatment options and support for parents to permit enrollment of their infants in trials that can expand the available body of evidence," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
THURSDAY, July 24, 2025 -- The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk...
Few School Principals Report District-Mandated Mental Health Screening
THURSDAY, July 24, 2025 -- Few school principals report district-mandated mental health screening in schools, according to a study published online July 18 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.